Issue 13, 2019

Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics

Abstract

A smart nanotheranostics nanoplatform was constructed using engineered graphene oxide and the in situ growth of ultrasmall superparamagnetic iron oxide particles (SPIONs). The construction of such a novel theranostics nanoplatform shows great potential in tumor theranostics, especially for T1-weighted magnetic resonance (T1-MR) imaging guided, pH-sensitive chemotherapy.

Graphical abstract: Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics

Supplementary files

Article information

Article type
Communication
Submitted
19 Nov 2018
Accepted
10 Jan 2019
First published
10 Jan 2019

Chem. Commun., 2019,55, 1963-1966

Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics

Y. Luo, Y. Tang, T. Liu, Q. Chen, X. Zhou, N. Wang, M. Ma, Y. Cheng and H. Chen, Chem. Commun., 2019, 55, 1963 DOI: 10.1039/C8CC09185D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements